The promise of assisted reproduction is often framed as a triumph of modern science over biological limits. However, for Ecuador, the path toward legislating these technologies is proving to be a complex intersection of medical hope and bioethical risk. During a recent series of technical consultations and academic meetings, Dr. Francisco Güell, a leading European researcher in the field, delivered a series of stark warnings regarding the legal and biological safeguards necessary to protect patients and future children.
Dr. Güell’s visit to the National Assembly was prompted by a critical review of the proposed law on assisted human reproduction. With over 15 years of experience and a history of leading European Union-funded projects analyzing clinic transparency across eight countries, Güell argues that the current legislative trajectory in Ecuador risks prioritizing market openness over public health. His analysis centers on the advertencias que un experto español expuso en Ecuador, focusing on the dangers of insufficient regulation and the potential for the country to become a hub for unregulated fertility practices.
At the heart of the debate is a fundamental tension: the desire to provide fertility solutions versus the responsibility to communicate the real, often understated, risks of these procedures. Güell’s intervention serves as a call for “prudential legislation,” urging lawmakers to move beyond a permissive framework and instead implement strict evidence-based protections.
The Hidden Biological Toll: Epigenetics and Childhood Health
One of the most technical yet critical aspects of Güell’s warning involves epigenetics—the study of how behaviors and environment can cause changes that affect the way genes work. To illustrate this, Güell used a culinary analogy, comparing the process to making a paella: the ingredients are necessary, but the precise amount of salt determines the outcome. In assisted reproduction, he argues, the “salt” is the regulation of gene expression, which can be disrupted during the process.
According to the researcher, various stages of assisted reproduction—including ovarian stimulation, the manipulation of gametes, embryonic culture, and the freezing process—can interfere with delicate biological markers. He noted that if a mother’s stress or nutrition can affect egg quality, then the aggressive nature of ovarian hyperstimulation can similarly alter the biological environment.
Drawing on systematic reviews, Güell highlighted an increased risk for a range of pathologies in children born through these techniques. These include:
- Congenital malformations detectable before birth.
- Perinatal complications, specifically those linked to prematurity and low birth weight.
- Long-term health issues, including cardiovascular disorders, immunological alterations, and certain types of childhood cancers.
Güell expressed concern that if any one of these risks were identified in a standard pharmaceutical drug, it would have triggered a global health alarm years ago. He advocates for a regulatory framework that mandates full transparency regarding these long-term health trajectories.
The Statistics Gap: Pregnancy vs. Live Births
A recurring issue in the fertility industry is the way success is measured and marketed. Güell warned that there is a dangerous lack of clarity in the percentages provided to prospective parents. He urged a strict distinction between the “pregnancy rate” (a positive test) and the “birth rate” (a child arriving home).
Citing data from national registries in France, Güell explained that success should be measured per initiated cycle. While a woman may increase her cumulative probability of success by undergoing multiple treatments, each individual cycle has a limited probability of resulting in a live birth. The danger, he argues, arises when clinics use early-stage pregnancy rates to suggest a higher level of certainty than actually exists.
This statistical ambiguity often leads to a misleading narrative that assisted reproduction is a guaranteed solution for those wishing to postpone motherhood. Güell asserted that it is not honest to present these techniques as a “safe” way to delay childbearing, as the efficacy of these treatments declines sharply with maternal age, regardless of the technology used. For more information on how age affects fertility, the Mayo Clinic provides detailed clinical guidelines on reproductive aging.
Ethical Hazards of the Egg Donation Market
The commercialization of human gametes is perhaps the most sensitive point of the current legislative debate. Spain, where Güell is based, is a leader in the European egg donation market, a reality that has provided him with a front-row seat to the potential for exploitation. In Spain, donations typically fetch between 1,000 and 1,500 euros (approximately $1,100 to $1,650 USD).
Güell warned that for young women facing economic hardship, this amount serves as a powerful incentive, transforming a medical donation into a financial transaction. He cautioned Ecuador against adopting flexible regulations that could inadvertently turn the country into an international “supply center” for gametes, where practices restricted in developed nations are permitted due to a lack of oversight.
Beyond the ethics, We find medical concerns. Güell pointed to research linking egg donation to a higher incidence of preeclampsia and gestational hypertension. He explained that when the embryo does not share a genetic load with the mother, the immunological response changes, potentially complicating the pregnancy.
Restorative Medicine and the Right to Identity
Rather than moving immediately to invasive and expensive technologies, Güell advocated for “restorative fertility medicine.” This approach prioritizes diagnosing the root cause of infertility—whether hormonal, metabolic, or anatomical—and attempting to reverse it before resorting to in vitro fertilization (IVF).
Finally, the researcher addressed the growing legal movement in Europe regarding the “right to identity.” Children born via anonymous donation are increasingly challenging the secrecy of their biological origins in court. Güell noted that the right to know one’s origins is no longer a minor philosophical point but a legal reality being debated in parliaments and courts across the globe.
| Concern Area | Risk Identified by Dr. Güell | Proposed Regulatory Safeguard |
|---|---|---|
| Patient Information | Confusion between pregnancy and birth rates | Mandatory reporting of live birth rates per cycle |
| Child Health | Epigenetic alterations and childhood cancers | Long-term health monitoring and transparency |
| Egg Donation | Economic exploitation of vulnerable women | Strict limits on financial incentives and oversight |
| Legal Rights | Anonymity of biological donors | Legislating the right to biological identity |
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Individuals seeking fertility treatment should consult with a licensed healthcare provider to discuss their specific medical history and options.
As Ecuador continues to refine its legal framework for assisted reproduction, the focus now shifts to the National Assembly’s response to these technical warnings. The next phase of the legislative process will determine whether the final law incorporates these bioethical safeguards or maintains a more permissive approach to the fertility industry.
We invite you to share your thoughts on the balance between medical innovation and bioethical regulation in the comments below.
